{"id":24790,"date":"2019-12-17T11:18:20","date_gmt":"2019-12-17T11:18:20","guid":{"rendered":"https:\/\/www.irdd-summit.com\/?page_id=24790"},"modified":"2021-03-19T10:22:15","modified_gmt":"2021-03-19T10:22:15","slug":"tonya-winders","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/tonya-winders\/","title":{"rendered":"Tonya Winders"},"content":{"rendered":"
\n

Tonya Winders<\/h2>\n

President and Chief Executive Officer of Allergy & Asthma Network<\/h4>\n\t

Tonya Winders. MBA is currently the President and Chief Executive Officer of Allergy & Asthma Network, the leading patient advocacy organization dedicated to ending the needless death and suffering due to asthma, allergies and related conditions.<\/p>\n

Tonya has over 17 years experience in leadership roles within the allergy and asthma industry. From sales and marketing leadership to managed markets access, she has worked tirelessly to ensure patients have access to effective diagnostic and treatment tools.<\/p>\n

Tonya serves on several expert panels including the ATS Public Advisory Roundtable & the NHLBI NAEPP. Furthermore, she is on the board of directors for Not One More Life, American Respiratory Care Foundation and is the current president of the Global Allergy Asthma Patient Platform, representing 38 patient organizations throughout the world.<\/p>\n

Personally, Tonya is the mother of five children, four of whom have asthma and\/or allergies, ranging in age from 13-19 years old (including Karson who has PN allergy). She enjoys spending time with her husband of 22 years Brian Winders and cheering on her children in various sports.<\/p>\n\t\t\t\t\t\t\t\t\t\t\"Tonya_Winders_Allergy_Asthma_Network_BioTech_Pharma_Summit_Inhalation_Respiratory_Drug_Delivery_Gallery\"” data-srcset=”https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2019\/12\/Tonya_Winders_Allergy_Asthma_Network_BioTech_Pharma_Summit_Inhalation_Respiratory_Drug_Delivery_Gallery.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2019\/12\/Tonya_Winders_Allergy_Asthma_Network_BioTech_Pharma_Summit_Inhalation_Respiratory_Drug_Delivery_Gallery-201×300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2019\/12\/Tonya_Winders_Allergy_Asthma_Network_BioTech_Pharma_Summit_Inhalation_Respiratory_Drug_Delivery_Gallery-686×1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2019\/12\/Tonya_Winders_Allergy_Asthma_Network_BioTech_Pharma_Summit_Inhalation_Respiratory_Drug_Delivery_Gallery-768×1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2019\/12\/Tonya_Winders_Allergy_Asthma_Network_BioTech_Pharma_Summit_Inhalation_Respiratory_Drug_Delivery_Gallery-630×940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2019\/12\/Tonya_Winders_Allergy_Asthma_Network_BioTech_Pharma_Summit_Inhalation_Respiratory_Drug_Delivery_Gallery-420×627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2019\/12\/Tonya_Winders_Allergy_Asthma_Network_BioTech_Pharma_Summit_Inhalation_Respiratory_Drug_Delivery_Gallery-315×470.jpg 315w”>\t\t\t\t\t\t\t\n

\n\tShared Decision Making to Improve Adherence in Severe Asthma\n\t<\/h3>\n\t